Patents by Inventor Joel T. Hargrove

Joel T. Hargrove has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and dosage form for treatment of premenstrual syndrome
    Patent number: 5140021
    Abstract: A pharmaceutical composition suitable for oral administration comprises micronized progesterone in an oil vehicle which is high in glycerides of polyunsaturated fatty acids. Micronized progesterone particles suspended in such an oil vehicle are absorbed more readily into the bloodstream and achieve high progesterone blood serum levels. The pharmaceutical composition according to the invention can be readily formulated into capsules and administered for the treatment of premenstrual syndrome.
    Type: Grant
    Filed: October 27, 1989
    Date of Patent: August 18, 1992
    Assignee: Genesis Systems Corporation
    Inventors: Wayne S. Maxson, Joel T. Hargrove, Philip G. Meyers
  • Method for treatment of premenstrual syndrome
    Patent number: 4963540
    Abstract: A pharmaceutical composition suitable for oral administration comprises micronized progesterone in an oil vehicle which is high in glycerides of polyunsaturated fatty acids. Micronized progesterone particles suspended in such an oil vehicle are absorbed more readily into the bloodstream and achieve high progesterone blood serum levels. The pharmaceutical composition according to the invention can be readily formulated into capsules and administered for the treatment of premenstrual syndrome.
    Type: Grant
    Filed: January 13, 1988
    Date of Patent: October 16, 1990
    Inventors: Wayne S. Maxson, Joel T. Hargrove, Philip G. Meyers
  • Novel pharmaceutical composition containing estradiol and progesterone for oral administration
    Patent number: 4900734
    Abstract: A pharmaceutical composition is provided for oral administration. The composition comprises estradiol dissolved in an oil vehicle containing a suspension of micronized progesterone. The oil vehicle is high in glycerides of polyunsaturated fatty acids. The estradiol and micronized progesterone contained in the oil are more readily absorbable in the blood stream and achieve enhanced estradiol and progesterone blood serum levels. The pharmaceutical composition according to the invention can be readily formulated into capsules and administered for the treatment of menopausal symptoms.
    Type: Grant
    Filed: August 27, 1987
    Date of Patent: February 13, 1990
    Inventors: Wayne S. Maxson, Joel T. Hargrove, Joe H. Delk